Venus Remedies Ltd

NSE: VENUSREM · BSE: 526953 · Pharmaceuticals & Biotechnology · 21 announcements

Share price: ₹1,769.40
Market cap: ₹2,365 Cr
Revenue (annual): ₹769.6 Cr
Net profit (annual): ₹102.8 Cr
P/E (TTM): 20.4×Sector 47.3×
Promoter holding: 41.76%+0.00% QoQ
FII holding: 2.92%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 8 Financial Results 4 Management Change 2 Annual General Meeting 2 Regulatory Approval 1 Dividend 1 Business Update 1 Board Meeting Outcome 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

20 Aug 2026 17:35 IST BSE

Management Change

Venus Remedies Management Change

Venus Remedies Ltd announced the appointment and re-appointment of several Directors, including Executive and Independent Directors, following approval at its 37th Annual General Meeting.

Read the filing ↗

26 May 2026 22:38 IST NSE

Management Change

Venus Remedies Management Change

Venus Remedies appointed Saransh Chaudhary and Gurminder Singh Bedi to its Board. It also re-appointed Manu Chaudhary and Savita Gupta, strengthening leadership for five-year terms.

Read the filing ↗